MedTrace Logo

Clinical Trial in Males With BPH (Enlarged Prostate)

NCT00029822 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1522

Last updated 2008-06-09

No results posted yet for this study

Summary

A study to determine the effect on prevention of Acute Urinary Retention (inability to urinate) in males with an enlarged prostate, also known as BPH.

* Free study-related medical care provided.

Conditions

  • Urinary Retention
  • Prostatic Hyperplasia
  • Benign Prostatic Hypertrophy

Interventions

DRUG

Alfuzosin (SL770499)

Sponsors & Collaborators

Principal Investigators

  • ICD CSD · Sanofi

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-05-31
Completion
2005-03-31

Countries

  • United States
  • Australia
  • Bulgaria
  • Canada
  • Denmark
  • Finland
  • Greece
  • Hungary
  • Israel
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • South Africa
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00029822 on ClinicalTrials.gov